MedTrace Logo

Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe)

NCT03171545 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1431

Last updated 2026-01-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is reduce episodes of intradialytic hypotension, low blood pressure during a hemodialysis session, in patients with End Stage Renal Disease (ESRD). Recruitment will take place on the clinic level rather than the patient level.

Conditions

Interventions

BEHAVIORAL

Patient Activation

Patients in clinics assigned to this group will be offered peer mentoring and digital resources.

BEHAVIORAL

Provider Education

Staff in clinics assigned to this group will receive team training and a checklist.

Sponsors & Collaborators

  • University of California, Irvine

    collaborator OTHER

  • National Kidney Foundation, United States

    collaborator OTHER

  • Fresenius Medical Care North America

    collaborator INDUSTRY

  • University of Michigan

    lead OTHER

Principal Investigators

  • Tiffany Veinot, PhD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-11
Primary Completion
2024-11-17
Completion
2024-12-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03171545 on ClinicalTrials.gov